181 related articles for article (PubMed ID: 22546767)
21. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
[TBL] [Abstract][Full Text] [Related]
22. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
Roberts JA; Field J; Visser A; Whitbread R; Tallot M; Lipman J; Kirkpatrick CM
Antimicrob Agents Chemother; 2010 Sep; 54(9):3635-40. PubMed ID: 20547809
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.
Nei SD; Wittwer ED; Kashani KB; Frazee EN
Pharmacotherapy; 2015 Aug; 35(8):e127-30. PubMed ID: 26242293
[TBL] [Abstract][Full Text] [Related]
24. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
Yang CJ; Wu CW; Wu CC
Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration.
Bouman CS
Curr Opin Crit Care; 2008 Dec; 14(6):654-9. PubMed ID: 19023912
[TBL] [Abstract][Full Text] [Related]
26. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury.
Atan R; Peck L; Prowle J; Licari E; Eastwood GM; Storr M; Goehl H; Bellomo R
Crit Care Med; 2018 Oct; 46(10):e988-e994. PubMed ID: 30074491
[TBL] [Abstract][Full Text] [Related]
27. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
[TBL] [Abstract][Full Text] [Related]
29. Plasma aluminum levels during sucralfate prophylaxis for stress ulceration in critically ill patients on continuous venovenous hemofiltration: a randomized, controlled trial.
Mulla H; Peek G; Upton D; Lin E; Loubani M
Crit Care Med; 2001 Feb; 29(2):267-71. PubMed ID: 11246304
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
[TBL] [Abstract][Full Text] [Related]
31. Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients.
Villa G; Cassetta MI; Tofani L; Valente S; Chelazzi C; Falsini S; De Gaudio AR; Novelli A; Ronco C; Adembri C
Int J Antimicrob Agents; 2015 Oct; 46(4):465-8. PubMed ID: 26315198
[TBL] [Abstract][Full Text] [Related]
32. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
Garbez N; Mbatchi LC; Maseda E; Luque S; Grau S; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
Ther Drug Monit; 2021 Dec; 43(6):747-755. PubMed ID: 33560097
[TBL] [Abstract][Full Text] [Related]
33. Dosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.
Bouman CS
Acta Clin Belg; 2007; 62 Suppl 2():365-70. PubMed ID: 18284001
[TBL] [Abstract][Full Text] [Related]
34. No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis.
Cobussen M; de Kort JM; Dennert RM; Lowe SH; Stassen PM
Infect Dis (Lond); 2016 Apr; 48(4):274-280. PubMed ID: 26567531
[TBL] [Abstract][Full Text] [Related]
35. Gentamicin clearance during continuous arteriovenous hemodiafiltration.
Ernest D; Cutler DJ
Crit Care Med; 1992 May; 20(5):586-9. PubMed ID: 1572182
[TBL] [Abstract][Full Text] [Related]
36. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin clearance in high-volume venovenous hemofiltration.
Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS
Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801
[TBL] [Abstract][Full Text] [Related]
38. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
Blot S; Lipman J; Roberts DM; Roberts JA
Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
[TBL] [Abstract][Full Text] [Related]
39. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
40. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration.
Bellmann R; Falkensammer G; Seger C; Weiler S; Kountchev J; Joannidis M
Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
